![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/27/2905032/0/en/Oculis-and-EURETINA-Announces-the-Ramin-Tadayoni-Award.html
https://www.fiercebiotech.com/biotech/oculis-sees-promise-dry-eye-disease-subgroup-plans-phase-3
https://www.globenewswire.com/news-release/2024/06/10/2895806/0/en/Oculis-Announces-Positive-Topline-Results-of-Phase-2b-RELIEF-Trial-with-Licaminlimab-Designed-to-Transform-the-Treatment-Paradigm-of-Dry-Eye-Disease-with-a-Precision-Medicine-Strat.html
https://www.globenewswire.com/news-release/2024/06/04/2893362/0/en/Oculis-Publishes-Notifications-of-Transactions-by-Persons-Discharging-Managerial-Responsibilities.html
https://www.globenewswire.com/news-release/2024/05/30/2890456/0/en/Oculis-Publishes-Results-of-2024-Annual-General-Meeting-and-Announces-Appointments-to-its-Board-of-Directors-and-Scientific-Advisory-Board.html
https://www.globenewswire.com/news-release/2024/05/17/2884489/0/en/Oculis-updates-share-capital-for-its-existing-at-the-market-offering-program.html
https://www.globenewswire.com/news-release/2024/05/08/2878259/0/en/Oculis-Reports-Q1-2024-Financial-Results-and-Provides-Company-Updates.html
https://www.globenewswire.com/news-release/2024/05/08/2878221/0/en/Oculis-Announces-Completion-of-Enrollment-in-Phase-2-Randomized-Controlled-ACUITY-Trial-with-OCS-05-for-Acute-Optic-Neuritis.html
https://www.globenewswire.com/news-release/2024/05/06/2875656/0/en/Oculis-to-Present-at-Bank-of-America-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/07/2877191/0/en/Oculis-Publishes-Invitation-to-the-Annual-General-Meeting.html